Contact Us | Useful Links | FAQs | Feedback | Sitemap |
 
   
 
Holdipharma Delegation gave a visit to the newdigging site of the Suez Canal :: Holdipharma welcomes the establishment of a production facility dedicated for production of raw materials :: Egyptian Exchange "Rings the Bell For Gender Equality " :: UNGC principles with holdipharma :: New chairman of Drug Holding Co. :: The Minister of the Business Sector is following up implementation plan :: Minister of Business Sector approved the estimated "DHC budget " 2017/2018 :: President Al Sisi directs the follow-up plans to develop public sector companies :: Minister of Business Sector receives Indian Ambassador :: Drug Holding Company: “Development Committee "ends the study of the Co. structure :: Ministry Of Public Business Sector: completion of the General Assemblies of DHCs :: Minister of Business Sector assigns 3 new members of Board of Directors of the DHC :: Chairman of Drug Holding Company: 11% is our share in the Egyptian drug market :: Captain Mohammed Wanees, one of the heroes of the glorious October War :: Minister of Business Sector: Restructuring the investment portfolio of the companies :: Appointment of a new President of the Drug Holding Company :: Hisham Anwar Tawfiq, Minister of Public Business sector, replacing Khaled Badawi . :: An integrated strategy for the advancement of the Drug Holding Company :: Dr.Ahmed Hegazy Chairman of Holdipharma Company confirm that Holdipharma reaffirms its support for the ten principles of the United Nations Global Compact :: The Ministry of Public Business Sector announces :: Holdipharma: Providing medical supplies to the hospitals of the Ministry of Health :: The National Bank and HoldiPharma sign a cooperation protocol ::
 
 
Company Details
Company Name   Website
Misr   www.misrpharma.com.eg
     
Description

Misr Company for pharmaceutical industries was founded in 1939 as the first Egyptian company for the pharmaceutical production of human and veterinary drugs, and it was totally financed by a pure Egyptian capital through the contribution of "Misr Bank " that was established by the Great Egyptian economist "Talaat Pasha Harb" to be the first nucleus for developing the national projects and for the creation  of an Egyptian industry to compete against the foreign goods that were controlling the Egyptian and Arab Markets at that time.

In 1956, the company had established a new facility at Matariya area in accordance to the latest industrial system requirements and was provided with the latest machinery automation needed for the establishment of modern pharmaceutical industry.

The company played a very important national role in providing the Egyptian army with its medicinal needs during the several wars carried out by Egypt besides fulfilling its national duty by providing medicinal demands for all the Arab and African countries.

Misr is an owned state Company and one of the affiliated companies to Holdipharma company.

 And to help the company to continue its successful history initiated by the Egyptian leaders,it was decided to demolish its main headquarter in Matariya and  go through a complete renovation and modernization by the establishment of a new factory at Abu Zaabal district outside the densely populated area and in accordance to the latest GMP requirements and to be able to apply  the international quality standards with  a fully equipped production lines.

Misr Company is uniquely characterized by the existence of a dedicated manufacturing line for the production of penicillins (β-lactam antibiotics) with all its dosage forms to serve most of pharmaceutical companies as a toll manufacturer for this specialized production.

Misr company also owes a modernized well-equipped sterile areas built in accordance to the highest level of quality to manufacture ampoules, drops, sterile eye ointments and specialized surgical ampoules like morphine and pethidine , that are produced with complete control to ensure the quality and safety and with affordable price.

Misr Company as a core company started to export its pharmaceutical products since the forties of the last century that was widely created as a good distinguished reputation in the Arab and African pharmaceutical market.

Board Members:

Dr/ Amal Abdel Karim Abdel Wahed                   Chairman of the Board and Managing Director

Dr / Maysara Zine El Abidin Abd Elhamed                            Non Executive Member

Mr/      Magdy Foad Abdallah                                                Non Executive Member

Dr/ Sayed Abbas  Mahmoud                                                    Elected Member

Mr/ Ahmed Alaa Aldeen                                                      Elected Member

Audit Committee:

Mr/ Yehia Mohamed Mahmoud                   Chairman

Mr/ Ahmed Raslan                                   From Accountability State Authority (previously)      

Mr/ Foad Sakr Ahmed                              Non Executive Member

 

Company Main Indicators (in thousands of Egyptian Pounds)

Indicator

2016-2017

2017-2018

     2018-2019

Net Operating Revenue

   241846

   327821

             345348

Interest Expenses

   0

   0

                  0

Net Income

   1001

   3638

                4224

Net Equity

239971

   240696

             263012

Working Capital

   30746

   41321

               70198

Total Investment

   246702

   633409

               266025

Salaries

   95466

   99167

                 108538

Number of workers

   1689

   1623

                 1679

     
Image Gallery
   
     
Related Links
Affiliates
   
Joint Venture
   
   
   
   
 
 
     
  Copyright © 2009 HOLDIPHARMA. All rights reserved.         Terms of Use | Privacy Statement | Disclaimer |